Based on Takeda's letter Posted Here, I'm upping my target to $30, if and When O is re-introduced!
No wonder the Shorties are all over the place here.
Hold folks as I said many times it is a once in a life time opportunity. Takeda won't be spending 8 months for a Drug where they can't fix the problem.
Some form or the other O will be returned to the market and it is worth in excess of $30, since once returned to market it is going to stay permenantly. Since Mercera too had numerous issues and FDA would place more restrictions.
It is a great opportunity, of course the risks are associated if Takeda withdraws its NDA itself, the chances of that occuring is.0001% and that too after 8 months of hard work and further millions spend.